Search results for "roe"

showing 10 items of 9822 documents

Repeated kidney re-transplantation—the Eurotransplant experience: a retrospective multicenter outcome analysis

2020

Transplant international (2020). doi:10.1111/tri.13569

re-transplantationOutcome analysis030230 surgeryKidneyALLOCATION0302 clinical medicine3RDfourthKidney transplantationKidneychildGraft SurvivalConfoundinglossSUCCESSrepeatedGRAFT LOSSCOMPETING RISKSTissue Donorsddc:Treatment Outcomesurgical procedures operativemedicine.anatomical_structure030211 gastroenterology & hepatologyOutcome dataLife Sciences & Biomedicinemedicine.medical_specialtykidneyTissue and Organ ProcurementRe transplantation610survival1ST03 medical and health sciencesmedicineHumansddc:6102NDRetrospective StudiesDeceased donorTransplantationScience & Technologybusiness.industrymedicine.diseaseKidney TransplantationSurgeryTransplantationRECIPIENTSgraftSurgeryHuman medicinebusinessthirdSINGLE-CENTER
researchProduct

Oxidative and nitrosative stress in the metastatic microenvironment.

2010

Metastases that are resistant to conventional therapies are the main cause of most cancer-related deaths in humans. Tumor cell heterogeneity, which associates with genomic and phenotypic instability, represents a major problem for cancer therapy. Additional factors, such as the attack of immune cells or organ-specific microenvironments, also influence metastatic cell behavior and the response to therapy. Interaction of cancer and endothelial cells in capillary beds, involving mechanical contact and transient adhesion, is a critical step in the initiation of metastasis. This interaction initiates a cascade of activation pathways that involves cytokines, growth factors, bioactive lipids and r…

reactive oxygen speciesCancer ResearchTumor microenvironmentCancerReviewBiologylcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.diseaselcsh:RC254-282Primary tumorMetastasischemistry.chemical_compoundImmune systemreactive nitrogen speciesOncologychemistryImmunologyCancer cellmedicineCancer researchCytotoxic T celltumor microenvironmentmetastasesReactive nitrogen speciesCancers
researchProduct

Contributo alla conoscenza della reazione di Roemer e Schilipkoeter

1974

reazione Roemer e SchilipkoeterSettore MED/42 - Igiene Generale E Applicata
researchProduct

Polysubstituted ferrocenes as tunable redox mediators

2018

A series of four ferrocenyl ester compounds, 1-methoxycarbonyl- (1), 1,1’-bis(methoxycarbonyl)- (2), 1,1’,3-tris(methoxycarbonyl)- (3) and 1,1’,3,3’-tetrakis(methoxycarbonyl)ferrocene (4), has been studied with respect to their potential use as redox mediators. The impact of the number and position of ester groups present in 1–4 on the electrochemical potential E1/2 is correlated with the sum of Hammett constants. The 1/1+–4/4+ redox couples are chemically stable under the conditions of electrolysis as demonstrated by IR and UV–vis spectroelectrochemical methods. The energies of the C=O stretching vibrations of the ester moieties and the energies of the UV–vis absorptions of 1–4 and 1+–4+ c…

redox mediator010402 general chemistryElectrosynthesis01 natural sciencesMedicinal chemistryRedoxFull Research Paperlcsh:QD241-441chemistry.chemical_compoundlcsh:Organic chemistryRedox titrationparamagnetic NMR spectroscopylcsh:ScienceElectrochemical potential010405 organic chemistryChemistryChemical shiftOrganic Chemistryferrocenespectroelectrochemistrycyclic voltammetry0104 chemical sciencesChemistryFerroceneProton NMRlcsh:QCyclic voltammetryBeilstein Journal of Organic Chemistry
researchProduct

Colonoscopic screening of first-degree relatives of patients with large adenomas: increased risk of colorectal tumors.

2007

International audience; Background & Aims: The risk of developing colorectal neoplasia is not well established among family members of individuals with large adenomas and screening strategies remain under debate in this population. This study aimed at quantifying the risk of colorectal adenomas and cancers using colonoscopic screening in first-degree relatives of patients with large adenomas. Methods: This case-control study was performed in 18 endoscopic units of French non-University Hospitals. A colonoscopy was offered to first-degree relatives of 306 index cases with adenomas ≥ 10 mm, if they were alive, aged 40-75 and could be contacted by the index case. Among 674 relatives meeting th…

relativeseducation.field_of_studymedicine.medical_specialty[SDV.GEN]Life Sciences [q-bio]/GeneticsHepatologymedicine.diagnostic_testbusiness.industryscreeningPopulationGastroenterologyCase-control studyColonoscopyOdds ratioGastroenterologycolorectal tumourscolonoscopyPredictive value of testsInternal medicinemedicineFirst-degree relativesRisk assessmenteducationbusiness[ SDV.GEN ] Life Sciences [q-bio]/GeneticsIndex case
researchProduct

Etanercept maintains the clinical benefit achieved by infliximab in patients with rheumatoid arthritis who discontinued infliximab because of side ef…

2007

Objective: To evaluate the efficacy of switching to etanercept treatment in patients with rheumatoid arthritis who already responded to infliximab, but presented side effects. Methods: Charts of 553 patients with rheumatoid arthritis were retrospectively reviewed to select patients who responded to the treatment with infliximab and switched to etanercept because of occurrence of adverse effects. Clinical data were gathered during 24 weeks of etanercept treatment and for the same period of infliximab treatment before infliximab was stopped. Disease Activity Score computed on 44 joints (DAS-44), erythrocyte sedimentation rate (ESR) 1st hour, Visual Analogue Scale (VAS) of pain, Health Assessm…

rheumatoid arthritisMaleConcise ReportArthritisGastroenterologyReceptors Tumor Necrosis FactorEtanerceptEtanerceptArthritis Rheumatoidimmune system diseasesImmunology and AllergyHealth Status Indicatorsskin and connective tissue diseasesmedicine.diagnostic_testbiologyAntibodies MonoclonalMiddle AgedC-Reactive ProteinTreatment OutcomeBiologic agents; etanercept; infliximab; infusion reactionRheumatoid arthritisErythrocyte sedimentation rateAntirheumatic AgentsFemalemedicine.drugmusculoskeletal diseasesAdultmedicine.medical_specialtyVisual analogue scaleImmunologyBlood Sedimentationinfusion reactionGeneral Biochemistry Genetics and Molecular BiologyRheumatologyInternal medicinemedicineHumansAdverse effectRetrospective StudiesChi-Square Distributionbusiness.industryTumor Necrosis Factor-alphaC-reactive proteinetanercept; infliximab; rheumatoid arthritismedicine.diseaseInfliximabInfliximabSurgeryBiologic agentsstomatognathic diseasesImmunoglobulin Gbiology.proteinbusinessinfliximabetanercept
researchProduct

Impact of operation duration on postoperative outcomes of minimally-invasive right colectomy

2022

Aim: Operation time (OT) is a key operational factor influencing surgical outcomes. The present study aimed to analyse whether OT impacts on short-term outcomes of minimally-invasive right colectomies by assessing the role of surgical approach (robotic [RRC] or laparoscopic right colectomy [LRC]), and type of ileocolic anastomosis (i.e., intracorporal [IA] or extra-corporal anastomosis [EA]). Methods: This was a retrospective analysis of the Minimally-invasivE surgery for oncological Right ColectomY (MERCY) Study Group database, which included adult patients with nonmetastatic right colon adenocarcinoma operated on by oncological RRC or LRC between January 2014 and December 2020. Univariate…

right colectomyGastroenterologylaparoscopyrobotic right colectomyoperating timeminimally-invasive surgery
researchProduct

Setaria tundra, what do we know, what is still to be discovered?

2021

Over the past years, the nematode species from the Onchocercidae family, Setaria tundra, has expanded its range by thousands of kilometres from subpolar to subtropical climate zone. Its presence has been confirmed in seven new countries. The appearance of this parasite in many other European countries, especially central and southern ones, is highly probable. In recent years, its mass appearance has led to the numerous fall of reindeer in Fennoscandia, thus causing significant economic damage. There is also a growing risk of its gradation in Central Europe, which threatens overpopulated wild deer species and possibly farm animals, however there is no information if other than mosquitoes blo…

roe deerreindeermosquitofilariosisSetaria tundrasetariosisAnnals of Parasitology
researchProduct

Ķīmisko elementu saturs dažādos rīsos

2018

Ķīmisko elementu saturs dažādos rīsos. Lāma E., zinātniskais vadītājs Dr. ķīm., doc. Rudoviča V. Bakalaura darbs, 43 lappuses, 13 attēli, 6 tabulas, 34 literatūras avoti, 10 pielikumi. Latviešu valodā. Pētījumā ķīmisko elementu (Zn, Mn, Cu, Se, Sr, Ba, Cd, As, Pb) saturs rīsu paraugos tika noteikts ar induktīvi saistītās plazmas masspektrometrijas metodi, liesmas un elektrotermālās atomabsorbciometrijas analīzes metodēm. Tika izvērtēta elementu masas daļa rīsu paraugos atkarībā no to klasifikācijas, apstrādes veida, ievākšanas valsts.

rīsitoksiskie elementiINDUKTĪVI SAISTĪTĀS PLAZMAS MASSPEKTROMETRIJAmikroelementiLIESMAS ATOMABSORBCIOMETRIJAĶīmija
researchProduct

Safety of Tyrosine Kinase Inhibitors in Patients With Differentiated Thyroid Cancer: Real-World Use of Lenvatinib and Sorafenib in Korea

2019

Background: Thyroid cancer has become the most common cancer in Korea. Generally, thyroid cancer patients have a good prognosis; however, 15–20% of patients experience recurrence or distant metastasis or are refractory to standard treatment. We assessed the safety of sorafenib and lenvatinib in patients with advanced or metastatic radioactive iodine-refractory differentiated thyroid cancers (DTC) consecutively treated at a tertiary center in South Korea.Methods: We retrospectively reviewed the charts of all consecutive patients with DTC treated during ≥6 months with lenvatinib (February 2016–April 2018) and sorafenib (January 2014–April 2018) at Gangnam Severance Hospital. Patients were tre…

safety0301 basic medicineSorafenibmedicine.medical_specialtyEndocrinology Diabetes and Metabolismdifferentiated thyroid cancerrefractory thyroid cancer030209 endocrinology & metabolismlenvatiniblcsh:Diseases of the endocrine glands. Clinical endocrinologyGastroenterologyPapillary thyroid cancer03 medical and health scienceschemistry.chemical_compoundEndocrinology0302 clinical medicineInternal medicinetyrosine kinase inhibitorsmedicineAdverse effectFollicular thyroid cancerThyroid cancerOriginal Researchlcsh:RC648-665business.industryStandard treatmentCancermedicine.disease030104 developmental biologychemistryadverse effectschart reviewsorafenibbusinessLenvatinibmedicine.drugFrontiers in Endocrinology
researchProduct